Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
ASN Neuro ; 14: 17590914221102075, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36050845

RESUMEN

SUMMARY STATEMENT: A2A receptor required previous D2 receptor activation to modulate Ca2+ currents. Istradefylline decreases pramipexole modulation on Ca2+ currents. Istradefylline reduces A2A + neurons activity in striatial microcircuit, but pramipexole failed to further reduce neuronal activity.


Asunto(s)
Dopamina , Trastornos Parkinsonianos , Adenosina , Animales , Trastornos Parkinsonianos/tratamiento farmacológico , Pramipexol , Receptores de Dopamina D2/fisiología , Roedores
2.
Neurobiol Dis ; 142: 104949, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32442680

RESUMEN

Long-term consequences of status epilepticus (SE) occur in a significant proportion of those who survive the acute episode. We developed an in vivo model of acute focal neocortical SE (FSE) to study long-term effects on local cortical structure and function and potential strategies to mitigate adverse consequences of SE. An acute 2 h episode of FSE was induced in anesthetized mice by epidural application of gabazine +4-aminopyridine over sensorimotor neocortex. Ten and 30 days later, the morphological and functional consequences of this single episode of FSE were studied using immunocytochemical and electrophysiological techniques. Results, focused on cortical layer V, showed astrogliosis, microgliosis, decreased neuronal density, and increased excitatory synapses, along with increased immunoreactivity for thrombospondin 2 (TSP2) and α2δ-1 proteins. In addition, neocortical slices, obtained from the area of prior focal seizure activity, showed abnormal epileptiform burst discharges along with increases in the frequency of miniature and spontaneous excitatory postsynaptic currents in layer V pyramidal cells, together with decreases in both parvalbumin immunoreactivity (PV-IR) and the frequency of miniature inhibitory postsynaptic currents in layer V pyramidal cells. Treatment with an approved drug, gabapentin (GBP) (ip 100 mg/kg/day 3×/day for 7 days following the FSE episode), prevented the gliosis, the enhanced TSP2- and α2δ-1- IR and the increased excitatory synaptic density in the affected neocortex. This model provides an approach for assessing adverse effects of FSE on neocortical structure and function and potential prophylactic treatments.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Gabapentina/uso terapéutico , Células Piramidales/efectos de los fármacos , Corteza Sensoriomotora/efectos de los fármacos , Estado Epiléptico/tratamiento farmacológico , Animales , Anticonvulsivantes/farmacología , Potenciales Postsinápticos Excitadores/efectos de los fármacos , Gabapentina/farmacología , Ratones , Corteza Sensoriomotora/fisiopatología , Estado Epiléptico/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...